Nmt 631 dvt_imaging-1
-
Upload
ljmcneill33 -
Category
Education
-
view
133 -
download
0
Transcript of Nmt 631 dvt_imaging-1
Radionuclide Venography
NMT 431
1
What is a Deep Vein Thrombosis
• A) a clot that could infarct the brain• B) a clot that could infarct the heart• C) a clot that could infarct the lungs• D) a clot that could infarct the liver
2
A DVT can form because of?
• A) genetics• B) long plane flight• C) spontaneous formation• D) trauma
3
Radionuclide Venography is the gold standard for detection of DVT.
• A) True• B) False
4
Radionuclide Venography• Imaging of acute deep-vein thrombosis (DVT) in the
lower extremities for patients who do not tolerate radiographic contrast material
• Clinical indications– Equivocal or technically inadequate ultrasound of legs
and high suspicion of acute DVT– Recurrent DVT to differentiate acute from chronic
disease– Acute onset of symptoms– Detection of acute thrombophlebitis (tagged RBC’s)
5
Major Veins of the Right Lower Limb
From McClintic RJ. Human Anatomy; 1983.6
7
8http://images.lifescript.com/images/ebsco/images/si55551528_ma.jpg
Main Veins of the Leg
DVT Diagnostic Approach
9
CLINICAL FINDINGS• LEG PAIN/SWELLING• POSITIVE “HOMAN’S SIGN” (PAIN ON
DORSIFEXION OF FOOT)• PALPABLE “CORD” SUPERFICIAL
THROMBOPHLEBITIS• 1/3 OF DVT’S ASYMPTOMATIC• OF DVT’S FOUND AT AUTOPSY ABOVE CALF,
ONLY 19% HAD SYMPTOMS/SIGNS
10
CLINICAL CONT’D.
• CONVERSELY, VENOGRAMS (+) FOR DVT IN ONLY 46% OF CLINICALLY SUSPECTED CASES
• DDX:– CELLULITIS– BAKER CYST (ESPECIALLY WITH RUPTURE)– HEMATOMA– ETC.
• CLINICAL FINDINGS: UNRELIABLE
11
12
http://www.consumerreports.org/health/resources/images/conditions/dvt-rash_default.jpg
http://img.medscape.com/pi/emed/ckb/vascular_surgery/459840-462390-3304.jpg
http://www.my-varicose-veins.com/images/phlebitispic.jpgPhlebitis
DIAGNOSTIC METHODS• CLINICAL (observation)
• CONTRAST VENOGRAM– SPIRAL CT
• DOPPLER(ultrasound)• D-DIMER (blood test)• NUCLEAR
13
Gold Standard
http://golds-coins.com/wp-content/uploads/2011/07/Gold-Coins-Pictures.jpg
Contrast Venography– “Gold Standard” for imaging DVT - when technically
adequate– can image entire lower extremities– sensitive in asymptomatic patients
Limitations – painful– technically inadequate/difficult to interpret in 10-30% of
cases1,2
1. Hirsh J et al. Circulation 1996; 93:2212-2245. 2. Anand SS et al. JAMA 1998; 279:1094-1099.
14
15
DVT
16
DVT
17
DVT
18
CONTRAST VENOGRAPHY CONT’D.COMPLICATIONS OF CONTRAST
VENOGRAM
• DVT CAUSED BY DYE IN PT WITHOUT DVT– IONIC CONTRAST - UP TO 25%– NONIONIC CONTRAST - UP TO 7%– NON ISOSMOLAR, NONIONIC - STUDIES
PENDING• ALLERGIC REACTION• RENAL AND OTHER TOXICITIES• DEATH
19
DIAGNOSTIC METHODS
• CLINICAL• CONTRAST VENOGRAM
• DOPPLER• D-DIMER• NUCLEAR
20
DUPLEX DOPPLER ULTRASOUND
• ONLY RELIABLE FROM INGUINAL LIGAMENT TO TAKE-OFF OF TIBIAL VEINS
• MULTIPLE TRIALS:– 92% SENSITIVITY (FOR ALL CLOT IN
LEG, EVEN THOUGH CALF VESSELS NOT SEEN)
– 99% SPECIFIC
21
DOPPLER CONT’D. METHOD
• PULSED DOPPLER/BETTER WITH COLOR
• COMPRESSION AT EVERY LEVEL FROM UPPER COMMON FEMORAL TO LOWER POPLITEAL (EVEN IF CLOT NOT SEEN, INCOMPLETE COMPRESSABILITY SUGGESTS PRESENCE OF CLOT)
22
NORMAL WITHOUT COMPRESSION
23
NORMAL WITH COMPRESSION
24
PARTIALLY OBSTRUCTING THROMBUS
25
26
Ultrasonography
Advantages
– high sensitivity (82-100%) for proximal DVT (thighs and knees) in patients with localizing signs and symptoms1
– fast– low cost per procedure
1. Rose SC. RSNA Categorical Course in Vascular Imaging. 1998:139-156.
27
DRAWBACKS TO VENOUS DOPPLER
• HEAVILY OPERATOR-DEPENDENT• SOME SEGMENTS MAY BE “BLIND” TO
SAMPLING• CALF VEINS USUALLY NOT STUDIED, BUT
WITH NEW GENERATION EQUIPMENT CALF VEINS CAN BE RELIABLY SEEN IN 60-90%; IF SEEN, DOPPLER 90% SENSITIVE AND SPECIFIC FOR CLOT IN THEM.
28
Anatomic Imaging Modalities
• Contrast Venography and Ultrasonography•
– not specific for acute DVT– cannot reliably differentiate acute from
non-acute DVT
29
DIAGNOSTIC METHODS
• CLINICAL• CONTRAST VENOGRAM• DOPPLER
• D-DIMER• NUCLEAR
30
D-DIMER: BLOOD TESTING FOR ACUTE THROMBOSIS
• DEGRADATION PRODUCT OF CIRCULATING CROSS-LINKED FIBRIN
• ELEVATED LEVELS IN ACUTE THROMBOSIS
31
RECENT LITERATURE REVIEW: (BECKER, et al ARCHIVES INT MED, MAY ‘96
• VARIOUS ASSAYS NOT STANDARDIZED (ELISA, LATEX, IMMUNOFILTRATION)
• STUDIES HAVE NOT LOOKED FOR PRESENCE OR ABSENCE OF BOTH DVT AND P.E.
(I.E. PT’S CONSIDERED FREE OF P.E. MAY HAVE HAD SILENT DVT, AND VICE VERSA)
32
DIAGNOSTIC METHODS
• CLINICAL• VENOGRAPHY• DOPPLER• D-DIMER
• NUCLEAR MEDICINE
33
NM Clinical Procedure
1) ID patient; verify physician’s order; review clinical indication for exam
2) Explain procedure to patient; obtain relevant medical history
34
Relevant Medical History
• Location/duration of edema, warmth, redness, pain in lower extremities
• Prior history of DVT• Arthritis/cellulitis• Varicose veins• Results of US • Results of d-dimer
test
• Predisposing factors– Recent pelvic, hip,
knee surgery– Recent trauma– Cancer– Estrogen therapy– Recent travel– CHF– Obesity– Family hx of
thrombosis
35
Clinical Procedure - cont’d3) Administer radiopharmaceutical intravenously
a) Tc-99m apcitide (Acutect) ~20 mCi( Note: This agent is not commercially available at this time)
A synthetic peptide that binds to activated platelet receptors, part of the blood clotting process. Because the peptide binds to activated receptors, it identifies acute (clots in the process of forming) from chronic thrombosis
b) 99m-Tc Maa ~6 mCi
c) 99m-Tc tagged RBC’s ~20-30 mCi
36
Clinical Procedure - cont’d4) Image patient (for Acutect)
Anterior/posterior: pelvis, thighs, knees, calves at 10 min and 60-90 min post injection
5) Sources of error ( for Acutect)- excess bladder activity- urinary catheter tubing/urine contamination- increased uptake in postsurgical sites, collateral or superficial veins
37
NUCLEAR VENOGRAPHY• 99MTc-MAA – injection in each foot dorsal
vein• SENSITIVITY 94%/SPECIFICITY 92%
(SIEGEL, USC)
• PRO’S: – LUNG PERFUSION; ILIACS/IVC
• CON’S: – CALF VEINS; NONOBSTRUCTING CLOT
WITHOUT COLLATERALS
38
39
Typical Positive DVT Nuclear Scan
Anterior Posterior
http://www.agenix.com/agen/images/picTV_info02.jpg
40
41
42
99m-Tc tagged RBC’s
• IV injection of tagged cells
• Normal: veins appear and disspate with time
• Abnormal: higher uptake in tissue and areas of swelling
43
Tc-99m Apcitide Scintigraphy• Specific for Acute DVT
NO Longer Commercially Available
44
Tc-99m Apcitide
GPIIb/IIIa binding region
99mTcapcitide
– a small synthetic peptide– 13 amino acids, mol. wt. 1392 Da
– binding region for the platelet GPIIb/IIIa receptor
– radiolabeled with Tc-99m 45
Binding to Platelet GPIIb/IIIa Receptors
fibrinogen
PlateletPlatelet
99mTcTc-99m apcitide
GPIIb/IIIa
GPIIb/IIIa Activated PlateletActivated Platelet
Tc-99m apcitideand fibrinogenbind to theGPIIb/IIIa receptors onactivated platelets
46
Tc-99m Apcitide
• How It Worked– Activated platelets are present in acute
thrombi– The GPIIb/IIIa receptor is expressed on
activated platelets– Tc-99m apcitide binds to the GPIIb/IIIa
receptor– Unbound Tc-99m apcitide clears rapidly
47
Advances in the Diagnosis ofVenous Thromboembolism
– Venous Thromboembolism• Clinical Importance • Diagnosis and Treatment
– Tc-99m Apcitide• Mechanism of Action• Clinical Results
– Clinical Applications
48
Imaging Acute DVT with Tc-99m Apcitide
• Standard Procedure– 20 mCi Tc-99m, 100 g peptide– Antecubital vein injection– Standard nuclear medicine gamma camera– Anterior and posterior planar images starting at 10 min
and 60-90 min
In some cases:– SPECT or delayed (3 h) planar images useful
49
Tc-99m Apcitide Normal Biodistribution
10 min 60 min 240 min
R anterior L L posterior R R anterior L L posterior R R anterior L L posterior R
41 year old female50An “Aunt Minnie” Type Scan www.auntminnie.com
Tc-99m Apcitide Negative Case 10 min 60 min 120 min
R anterior L L posterior R
R anterior L L posterior R
R anterior L L posterior R
Patient History: 34y female, no prior history of DVT or PE, 2 days from onset of signs and symptoms in right calf, knee and thigh; venogram negativeTc-99m Apcitide Findings: negative for acute DVT
239551
Tc-99m Apcitide Positive Case
10 min 60 min 120 min
R anterior L L posterior R
R anterior L L posterior R
R anterior L L posterior R
Patient History: 66y male, prior history of DVT and PE, 5 days from onset of signs and symptoms in right calf and knee, on heparin and warfarin; venogram positive right calf and popliteal veinsTc-99m Apcitide Findings: acute DVT in right calf, knee and (distal) thigh 437052
Tc-99m Apcitide
•Biodistribution and Dosimetry– rapid urinary excretion over 24 hours (84-99%)– hepatobiliary excretion = 6% over 24 h– blood pool approx. 10% ID at 60 min– mean effective dose equivalent = 0.034 rem/mCi– maximum absorbed radiation dose (to urinary
bladder wall) = 0.22 rad/mCi– estimated biological half-life = 1.9 h
53
References
• Pete Shackett, 2nd edition, Nuclear Medicine Technology Procedures and Quick References
• http://www.nucmedtutorials.com/pp/dvt.ppt
• http://www.clevelandclinicmeded.com/medicalpubs/micu/diagnosticdvt.htm
54